Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kadmon Reveals A Bit Of Its Hand To Investors

This article was originally published in The Pink Sheet Daily

Executive Summary

Kadmon CEO Sam Waksal - the former CEO of ImClone - laid out the startup's ambitious pipeline during the Jeffries Healthcare Conference.
Advertisement

Related Content

Telaprevir Labeling Advantages Should Offset Higher Price In Hepatitis C Battle
Back In Biotech, Waksal's Kadmon Emerges From Stealth Mode To Focus on Hep C
Back In Biotech, Waksal's Kadmon Emerges From Stealth Mode To Focus on Hep C

Topics

Advertisement
UsernamePublicRestriction

Register

PS072479

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel